Follow us

  • X
  • Youtube

News Release

Event Calendar
World Orphan Drug Congress Asia
Release
Patent Allowance for Etuary and F351 in the U.S.
Release
Notice for completion of the registration of incorporation of a subsidiary
Release
Notice of Changing of Accounting Auditor
Release
Announcement of the 13th Annual General Shareholder Meeting
Release
Notice for the drug price and sales commencement for Etuary
Release
Notice for Exercise of the 37th Round of Stock Options in January, 2014
Release
Notice for establishment of distributors
Release
Notice for Large Volume Exercise and Completion of the 37th Round of Stock Option
Release
Notice for F647 commercial name
Release
GNI Group Receives Manufacture Approval for F647 from China FDA for First Idiopathic Pulmonary Fibrosis Drug in China
Release
（Amendment）GNI Group Receives Manufacture Approval for F647 from China FDA for First Idiopathic Pulmonary Fibrosis Drug in China
Release
Notice for Exercise of the 37th Round of Stock Options in December, 2013
Release
Notice for Large Volume Exercise of the 37th Round of Stock Option
Release
GNI Group Ltd. Announces a Licensing Agreement for its IPF therapy drug Etuary with AFT Pharmaceuticals for the ASEAN, Australasian and CIS Markets